ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    The Incidence and Outcomes of Fever of Unknown Origin After Pancreas Transplantation.

    R. Klasek,1 S. Kuten,1 S. Patel,1,3 D. Nguyen,1 E. Graviss,1 A. Gaber,1 R. Knight.1

    1Houston Methodist Hospital, Houston, TX; 2Veloxis Pharmaceuticals, Cary, NC

    Previous studies have shown that approximately 20% of febrile episodes in transplant recipients are not associated with infection. At our center, fever of unknown origin…
  • 2017 American Transplant Congress

    Novel Application of Localized Nanodelivery of Anti-IL6 Protects Organ Transplant from Ischemia Reperfusion Injuries.

    M. Uehara,1 Z. Solhjou,1 B. Bahmani,1 O. Maarouf,1 T. Ichimura,2 C. Brooks,2 W. Xu,1 V. Kasinath,1 N. Banouni,1 A. Elkhal,3 I. Guleria,2 M. McGrath,1 S. Tullius,3 R. Abdi.1

    1Transplantation Research Center/Renal Devision, Brigham and Women's Hospital/ Harvard Medical School, Boston; 2Renal Division, Brigham and Women's Hospital/ Harvard Medical School, Boston; 3Division of Transplant Surgery and Transplantation Surgery Research Laboratory, Brigham and Women's Hospital/ Harvard Medical School, Boston

    Ischemia reperfusion injury (IRI) evokes major intra-graft inflammatory responses that markedly augment alloimmune responses. Understanding mechanisms involved is critical for the development of novel therapeutic…
  • 2017 American Transplant Congress

    Contrast-Induced Acute Kidney Injury in Kidney Transplant Recipients: A Meta-Analysis.

    W. Cheungpasitporn,1 C. Thongprayoon,1 M. Mao,1 S. Mao,2 M. D'Costa,1 W. Kittanamongkolchai,1 K. Kashani.1

    1Nephrology and Hypertension, Mayo Clinic, Rochester, MN; 2Transplantation Surgery, Mayo Clinic, Rochester

    OBJECTIVE: To evaluate the incidence of contrast-induced acute kidney injury (CIAKI) in kidney transplant recipients.METHODS: A literature search was performed using MEDLINE, EMBASE, and the…
  • 2017 American Transplant Congress

    A Phase Ib, Open Label, Single Arm Study to Assess the Safety, Pharmacokinetics, and Impact on Humoral Sensitization of SANGUINATE Infusion in Patients with End-Stage Renal Disease.

    B. Abu Jawdeh,1 E. Woodle,1 A. Leino,1 T. Dorst,1 M. Abdallah,1 A. Govil,1 D. Byczkowski,2 H. Misra,2 A. Abuchowski,2 R. Alloway.1

    1U.Cincinnati, OH; 2Prolong Pharmaceuticals, NJ

    Purpose:The endeavor and resources spent to study desensitization haven't been matched by an effort to investigate strategies to prevent sensitization.The purpose of this study was…
  • 2017 American Transplant Congress

    Long-Term Persistence of Anti-HLA Antibodies in Renal Trasplant Recipients: Risk Factors and Impact on Clinical Course.

    I. Perez-Flores,1 J. Santiago,2 B. Rodriguez-Cubillo,1 M. Moreno De La Higuera,1 V. Lopez De La Manzanara,1 J. Bautista-Cañas,1 N. Calvo Romero,1 A. Shabaka,1 E. Urcelay,2 A. Sanchez-Fructuoso.1

    1Nephrology, Hospital Clínico San Carlos, Madrid, Spain; 2UGC Immunology, Hospital Clínico San Carlos and Instituto de Investigación Sanitaria (IdISSC), Madrid, Spain

    Objectives:1) To evaluate the incidence of development of anti-HLA antibodies on the long run in our renal transplant population and the main risk factors for…
  • 2017 American Transplant Congress

    Clinical Outcomes of Kidney Transplant Recipients by Steroid Early Withdraw Protocol with Basiliximab Induction.

    Y. Takada, K. Hotta, D. Iwami, H. Higuchi, T. Hirose, H. Sasaki, N. Shinohara.

    Urology, Hokkaido University Hospital, Sapporo, Japan

    [Purpose] Several steroid early withdrawal protocols (SEWD) have been attempted in recent decades to avoid steroid related adverse effects among kidney transplant recipients. However, there…
  • 2017 American Transplant Congress

    Combined Endoscopic and Percutaneous Cholangiography for Biliary Anastomotic Stricture in Adult Right-Lobe Living-Donor Liver Transplantation.

    A. Thorat,1 W.-H. Huang,2 C.-J. Yu,2 C.-Y. Peng,2 H.-R. Yang,1 C.-C. Yeh,1 T.-H. Chen,1 S.-C. Hsu,1 L.-B. Jeng.1

    1Organ Transplantation, China Medical University Hospital, Taichung, Taiwan; 2Internal Medicine, China Medical University Hospital, Taichung, Taiwan

    Background:Biliary anastomotic stricture isthe most common biliary complication after living donor liver transplantation (LDLT) that may be potentially life threatening if biliary sepsis occurs.Endoscopic retrograde…
  • 2017 American Transplant Congress

    Prolonged Cold Ischemia Time as a Risk for Low Regeneration at the Early Phase After Living Donor Liver Transplantation.

    K. Takahashi,1,2 S. Nagai,1 M. Safwan,1 K. Putchakayala,1 M. Rizzari,1 K. Collins,1 A. Yoshida,1 G. Schnickel,1 M. Abouljoud.1

    1Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI; 2Surgery, University of Tsukuba, Tsukuba, Ibaraki, Japan

    Background. The objective of this study was to determine the risk factors for low liver regeneration at the early phase after living donor liver transplantation…
  • 2017 American Transplant Congress

    The Impact of Insurance Status on Waiting List and Post-Lung Transplant Survival in Patients with Cystic Fibrosis.

    C. Lehr,1 M. Skeans,2 E. Dasenbrook,1 M. Valapour.1,2

    1Cleveland Clinic, Cleveland, OH; 2Scientific Reg of Transplant Recipients, Minneapolis, MN

    Studies show that insurance status at the time of wait-listing affects waitlist and posttransplant survival after lung transplant. No studies have analyzed the effect of…
  • 2017 American Transplant Congress

    The Impact of Scleroderma Diagnosis on Lung Transplant Outcomes: A Single Center's Experience.

    H. Memon, A. Frost, E. Graviss, D. Nguyen, A. Goodarzi, N. Sinha.

    Medicine, Weill Cornell Medical College, Houston Methodist Hospital, Houston, TX

    Patients with scleroderma (SSC) associated restrictive lung disease (RD) and pulmonary hypertension (PH) are often turned down for lung transplant due to associated co-morbidities, particularly…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences